abstract |
Compounds that are dual aP2/k-FABP inhibitors are provided having the formula n n n wherein A, B, X, Y, R 1 , R 2 and R 3 are as described herein. n A method is also provided for treating diabetes and related diseases, especially Type II diabetes, employing dual aP2/k-FABP inhibitors alone or in combination with at least one other antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin. |